✦ LIBER ✦
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
✍ Scribed by Harrison, Claire; Kiladjian, Jean-Jacques; Al-Ali, Haifa Kathrin; Gisslinger, Heinz; Waltzman, Roger; Stalbovskaya, Viktoriya; McQuitty, Mari; Hunter, Deborah S.; Levy, Richard; Knoops, Laurent; Cervantes, Francisco; Vannucchi, Alessandro M.; Barbui, Tiziano; Barosi, Giovanni
- Book ID
- 118008755
- Publisher
- Massachusetts Medical Society
- Year
- 2012
- Tongue
- English
- Weight
- 641 KB
- Volume
- 366
- Category
- Article
- ISSN
- 0096-6762
No coin nor oath required. For personal study only.